Hampus Hillerstrom is President and CEO of LuMind RDS Foundation since September 2017, after serving on the board of directors for three years, including one year as Vice-Chair. Previously, he co‐founded Proclara Biosciences in 2007, a company developing a novel approach for treating Alzheimer’s, Parkinson’s and other protein misfolding diseases, and, he served as EVP and CFO prior to joining LuMind RDS as CEO. Previously, he was an associate at leading European biotech venture capital firm HealthCap. Hampus also spearheaded a project at AstraZeneca to evaluate decision‐making leading to Phase III clinical trials and worked on the pharmaceutical industry at investment bank Lazard. Hampus holds a Masters in Economics from the University of St. Gallen, an MBA from Harvard Business School, and an MSc in Health Sciences and Technology from MIT/Harvard Medical School. Hampus has two sons, including 9 year old Oskar who has Down Syndrome.